lly glp 1 drug FDA Grants Speedy Approval to Eli Lilly's Oral GLP-1 RA for Obesity Eli Lilly and Company (LLY)
Description
Larger molecules face greater difficulty crossing biological membranes
Tirzepatide showed greater reductions in HbA1c and body weight at week 52, along with a lower risk of hypoglycemia [67]
Never miss a dose or double-dose by accident
Thomas Rutledge, a professor of psychiatry at UC San Diego, compares it to living for years with a fire alarm that never stops, only to experience a few months of silence
